Abstract:Glioblastoma, a grade IV astrocytoma, is regarded as the most aggressive primary brain tumour with an overall median survival of 16.0 months following the standard treatment regimen of surgical resection, followed by radiotherapy and chemotherapy with temozolomide. Despite such intensive treatment, the tumour almost invariably recurs. This poor prognosis has most commonly been attributed to the initiation, propagation, and differentiation of cancer stem cells. Despite the unprecedented advances in biomedical research over the last decade, the current in vitro models are limited at preserving the inter- and intra-tumoural heterogeneity of primary tumours. The ability to understand and manipulate complex cancers such as glioblastoma requires disease models to be clinically and translationally relevant and encompass the cellular heterogeneity of such cancers. Therefore, brain cancer research models need to aim to recapitulate glioblastoma stem cell function, whilst remaining amenable for analysis. Fortunately, the recent development of 3D cultures has overcome some of these challenges, and cerebral organoids are emerging as cutting-edge tools in glioblastoma research. The opportunity to generate cerebral organoids via induced pluripotent stem cells, and to perform co-cultures with patient-derived cancer stem cells (GLICO model), has enabled the analysis of cancer development in a context that better mimics brain tissue architecture. In this article, we review the recent literature on the use of patient-derived glioblastoma organoid models and their applicability for drug screening, as well as provide a potential workflow for screening using the GLICO model. The proposed workflow is practical for use in most laboratories with accessible materials and equipment, a good first pass, and no animal work required. This workflow is also amenable for analysis, with separate measures of invasion, growth, and viability.

Protocol using ex vivo mouse brain slice culture mimicking in vivo conditions to study tumor growth and cell motility of glioblastoma cells

Development and validation of an advanced ex vivo brain slice invasion assay to model glioblastoma cell invasion into the complex brain microenvironment

The Comparison Genomics Analysis with Glioblastoma Multiforme (GBM) Cells under 3D and 2D Cell Culture Conditions

Protocol to generate two distinct standard-of-care murine glioblastoma models for evaluating novel combination therapies

Engineering a High-Throughput 3-D In Vitro Glioblastoma Model

Invasion and anti-invasion research of glioma cells in an improved model of organotypic brain slice culture

Modeling glioblastoma tumor progression via CRISPR-engineered brain organoids

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy

Establishment of an orthotopic glioblastoma mouse model for preclinical studies

Protocol for in vitro evaluation of effects of stiffness on patient-derived glioblastoma

3D Brain Vascular Niche Model Captures Invasive Behavior and Gene Signatures of Glioblastoma

Behaviors of Glioblastoma Cells in in Vitro Microenvironments

Utility of the Cerebral Organoid Glioma 'GLICO' Model for Screening Applications

Anatomically aware simulation of patient-specific glioblastoma xenografts

A neural tract-inspired conduit for facile, on-demand biopsy of glioblastoma

Generating Patient-Derived Gliomas within Cerebral Organoids

Novel Brain-Stiffness-Mimicking Matrix Gel Enables Comprehensive Invasion Analysis of 3D Cultured GBM Cells

Two-Photon Intravital Microscopy of Glioblastoma in a Murine Model

Engineered In Vitro Tumor Model Recapitulates Molecular Signatures of Invasion in Glioblastoma

Tmic-34. Infiltrative Behavior Of Patient-Derived Glioblastoma Cell Lines In Region-Specific Human Brain Organoids